As of Oct 20
| +0.87 / +1.01%|
The 22 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 92.00, with a high estimate of 105.00 and a low estimate of 73.00. The median estimate represents a +5.47% increase from the last price of 87.23.
The current consensus among 24 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.